tradingkey.logo
tradingkey.logo
Search

bioAffinity Technologies Inc

BIAF
Add to Watchlist
0.778USD
-0.011-1.37%
Close 07/09, 16:00ETQuotes delayed by 15 min
4.89MMarket Cap
LossP/E TTM

bioAffinity Technologies Inc Earnings Date

Period
FY2025 Earnings Date
Revenue(YoY)
6.16M
-34.18%
EPS(YoY)
-8.66
61.27%
Analyst Rating
HOLD
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its total revenue reached 6.16M, with a year-on-year change of -34.18.

What are the current assets of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its current assets were 7.57M, with a year-on-year change of 180.70.

What are the total assets of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its total assets of bioAffinity Technologies Inc were 10.96M, with a year-on-year change of 68.27.

What are the total liabilities of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its total liabilities of bioAffinity Technologies Inc were 3.68M, with a year-on-year change of -5.84.

What is the total equity of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its total equity of bioAffinity Technologies Inc was 7.28M, with a year-on-year change of 179.69.

What is the net investment of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its net investment of bioAffinity Technologies Inc was -60.57K, with a year-on-year change of 23.41.

What is the net financing of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its net financing of bioAffinity Technologies Inc was 14.73M, with a year-on-year change of 161.82.

What is the Earnings Per Share (EPS) of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.66, with a year-on-year change of 61.27.

What is the net margin of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its net profit margin was -241.96, with a year-on-year change of -150.59.

What is the gross margin of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its gross margin was 23.21, with a year-on-year change of -21.63.

What is the debt-to-asset ratio of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its debt-to-asset ratio was 7.47, with a year-on-year change of -52.84.

What is the Return on Equity (ROE) of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its Return on Equity (ROE) was -301.83, with a year-on-year change of -24.49.

What is the Return on Assets (ROA) of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its Return on Assets (ROA) was -170.65, with a year-on-year change of -39.08.

What is the operating profit of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its operating profit was -10.57M, with a year-on-year change of -18.08.
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.